Search

Wei He He

from Sacramento, CA
Age ~70

Wei He Phones & Addresses

  • 1968 University Park Dr, Sacramento, CA 95825
  • Rockville, MD
  • New Orleans, LA
  • Gaithersburg, MD
  • Chicago, IL
  • Mobile, AL
  • Baltimore, MD
  • West Sacramento, CA

Professional Records

Lawyers & Attorneys

Wei He Photo 1

Wei He - Lawyer

View page
Address:
Clifford Chance LLP
(106) 535-2288 (Office)
Licenses:
New York - Currently registered 2010
Education:
Cornell Law School
Specialties:
Antitrust / Trade Law - 34%
Arbitration - 33%
Litigation - 33%
Wei He Photo 2

Wei He - Lawyer

View page
Office:
Clifford Chance LLP
Specialties:
M&A Corporate
ISLN:
922090745

Resumes

Resumes

Wei He Photo 3

Wei He

View page
Work:
INVOA Fairfax Hospital
Falls Church, VA
2013 to 2014

INVOA Fairfax Hospital

2013 to 2014
Respiratory therapy Tutor

Virginia Hospital Center
Arlington, VA
2013 to 2014
Ventilator management

Children's National Medical Center
Washington, DC
2013 to 2014

Mary Washington Hospital
Fredericksburg, VA
2013 to 2013
Excellent management

Sentara Medical Center
Woodbridge, VA
2013 to 2013

SEARS

2007 to 2013
Customer consultant

Education:
Northern Virginia Community College
Springfield, VA
May 2014
Associate of Applied Science

Wei He Photo 4

Wei He Cupertino, CA

View page
Work:
IVDiagnositcs

Feb 2008 to Dec 2011
Chief Technology Officer

Purdue University
Chicago, IL
2009 to 2010
Co-Director, Regulatory and Quality Compliance Program for Medical Devices

Education:
Kellogg School of Management, Northwestern University
Evanston, IL
Jan 2011
Master of Business Administration in Finance and Marketing

Purdue University
West Lafayette, IN
May 2008
Ph.D. in Chemistry

University of Science & Technology of China
Jul 2002
B.S. in Biochemistry & Analytical Chemistry

Wei He Photo 5

Wei He Gaithersburg, MD

View page
Work:
Wagner Resources, Inc.

Apr 2013 to 2000
Financial Analyst

Pacific Northwest National Laboratory, Joint Global Change Research Institute
College Park, MD
Jul 2012 to Dec 2012
Program Specialist

University of Maryland Economics Department
College Park, MD
Sep 2011 to May 2012
Teaching Assistant

Education:
University of Maryland - College Park
College Park, MD
2009 to 2012
Bachelor of Science in Finance

University of Maryland - College Park
College Park, MD
2009 to 2012
Bachelor of Science in Supply Chain Management

Skills:
MS Office: Excel (high proficiency), Word, Visio, Access, Project, Lync, Outlook, Powerpoint Entry level knowledge in SAP, Oracle, SQL, HTML, and QuickBook Familiar with other finance and accounting, payroll, and project management software
Wei He Photo 6

Wei He Gaithersburg, MD

View page
Work:
Bioinnovatise Part

Jan 2010 to 2000
Full Charge Bookkeeper

Non Profit
Rockville, MD
Jan 2007 to Jul 2009
Full Charge Bookkeeper

Yeshiva of Greater Washington
Silver Spring, MD
Jan 2006 to Jan 2007
Bookkeeper

RAS Investment, Inc
Rockville, MD
Jan 2001 to 2007
Sales Tax

Chinese Culture and Community Center

Mar 2003 to Dec 2006
Full Charge Bookkeeper

Quinn, Lynch & Lobel CPA Firm
Washington, DC
Sep 1999 to Dec 2000
Full Charge Bookkeeper

Federal Management Systems, Inc
Washington, DC
May 1998 to Aug 1999
Staff Accountant

Fujian Agricultural University, Fuzhou, Fujian, China

1985 to 1993
Accountant

MaAnShan Paper Mill Company, MaAnShan

1977 to 1984
Accountant

Education:
University of
South Alabama, NY
2002 to 2003
Accounting

East Los Angeles College
1995 to 1997
Certificate in Accounting

Business Records

Name / Title
Company / Classification
Phones & Addresses
Wei Dong He
Director
China Interactive Education, Inc
Wei Wu He
Director
MITHRAGEN, INC
Biotech Research
8030 El Rio St, Houston, TX 77054
Etp 1901 Research Blvd SUITE 350, Rockville, MD 20850
(713) 842-6188

Publications

Isbn (Books And Publications)

Chun Zhu Ji Wen

View page
Author

Wei He

ISBN #

7101017606

Us Patents

Human Prostatic Specific Reductase

View page
US Patent:
6344198, Feb 5, 2002
Filed:
Jul 27, 1998
Appl. No.:
09/123386
Inventors:
Wei W. He - Columbia MD
Paul S. Meissner - Barnesville MD
Peter L. Hudson - Germantown MD
Craig A. Rosen - Laytonsville MD
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
A61K 39395
US Classification:
4241391, 4241301, 4241331, 4241381, 4241411, 4241421, 4241431, 4241521, 4241721, 4241741, 5303871, 5303877, 5303881, 53038815, 5303873, 5303888
Abstract:
A human prostatic specific reductase polypeptide and polynucleotides encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polynucleotides as a diagnostic marker for prostate cancer and as an agent to determine if the prostate cancer has metastasized. Also disclosed are antibodies specific to the prostatic specific reductase polypeptide which may be used to target prostate cancer cells and be used as part of a prostate cancer vaccine. Methods of screening for agonists and antagonists for the polypeptide and therapeutic uses of the antagonists are also disclosed.

Interleukin-1 Converting Enzyme Like Apoptosis Protease-3 And 4

View page
US Patent:
6495519, Dec 17, 2002
Filed:
Jul 28, 1998
Appl. No.:
09/124934
Inventors:
Wei Wu He - Columbia MD
Craig A. Rosen - Laytonsville MD
Peter L. Hudson - Germantown MD
Gregg A. Hastings - Rockville MD
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
A61K 3848
US Classification:
514 12, 435226, 435219, 424 9463, 424 9465, 530350
Abstract:
Disclosed are human interleukin-1 converting enzyme like apoptosis proteases-3 and 4 and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and antibodies and antagonists against such polypeptides. Also provided are methods of using the polypeptides, for example, as an antitumor agent, and antiviral agent, and antibodies and antagonists against such polypeptides for example, for treating Alzheimers disease, Parkinsons disease, rheumatoid arthritis and head injury.

Prostatic Growth Factor

View page
US Patent:
6500638, Dec 31, 2002
Filed:
Jul 28, 1999
Appl. No.:
09/361741
Inventors:
Peter L. Hudson - Germantown MD
Craig A. Rosen - Laytonsville MD
Wei Wu He - Columbia MD
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
A61K 3817
US Classification:
435 691, 435 697, 4353201, 435325, 514 2, 514 12, 530350
Abstract:
The present invention relates to human PGF polypeptides and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques, and antibodies and antagonist/inhibitors against such polypeptides. Also provided are methods of using such polypeptides therapeutically for treating prostate cancer, to promote tissue regeneration and to facilitate wound healing. Also provided is a diagnostic assay to detect prostate cancer and benign prostatic hyperplasia.

Polynucleotides Encoding Prostatic Growth Factor And Process For Producing Prostatic Growth Factor Polypeptides

View page
US Patent:
6521227, Feb 18, 2003
Filed:
Dec 18, 1999
Appl. No.:
09/461418
Inventors:
Peter L. Hudson - Germantown MD, 20874
Craig A. Rosen - Laytonsville MD, 20882
Wei Wu He - Columbia MD, 21045
International Classification:
A61K 3942
US Classification:
4241331, 4241351, 4241391, 4241451, 5303873, 5303881, 53038824, 5303892
Abstract:
The present invention relates to human PGF polypeptides, DNA (RNA) encoding such polypeptides, and antibodies specifically binding such polypeptides. Also provided are procedures for producing such polypeptides by recombinant techniques, and for producing antibodies and antagonist/inhibitors against such polypeptides. Also provided are methods of using the polypeptide therapeutically for treating prostate cancer, promoting tissue regeneration, and facilitating wound healing. Further provided are methods of using such antibodies therapeutically to inhibit the action of PGF polypeptides and for the treatment of PGF-dependent tumors. Also provided is a diagnostic assay to detect prostate cancer and benign prostatic hyperplasia.

Interleukin-1 Converting Enzyme Like Apoptosis Protease-3 And 4

View page
US Patent:
6538121, Mar 25, 2003
Filed:
Nov 1, 1994
Appl. No.:
08/334251
Inventors:
Wei Wu He - Columbia MD
Craig A. Rosen - Laytonsville MD
Peter L. Hudson - Germantown MD
Gregg A. Hastings - Rockville MD
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
C15N 1557
US Classification:
536 232, 536 235, 435 691, 435226, 4353201
Abstract:
Disclosed are human interleukin-1 converting enzyme like apoptosis proteases-3 and 4 and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and antibodies and antagonists against such polypeptides. Also provided are methods of using the polypeptides, for example, as an antitumor agent, and antiviral agent, and antibodies and antagonists against such polypeptides for example, for treating Alzheimers disease, Parkinsons disease, rheumatoid arthritis and head injury.

Human Choline Acetyltransferase

View page
US Patent:
6656743, Dec 2, 2003
Filed:
Jun 24, 2002
Appl. No.:
10/177158
Inventors:
Peter L. Huson - Germantown MD
Wei Wu He - Columbia MD
Craig A. Rosen - Laytonsville MD
Jeannine D. Gocayne - Potomac MD
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
C12N 910
US Classification:
436193
Abstract:
Human choline acetyltransferase polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for the treatment of cognitive and neurological deficiencies or mental disturbances such as degenerative nervous system disorders, for example, Alzheimers Disease, ALS and other cholinergic defects, and antagonists for treating Parkinsons Disease and other disorders relating to an over-expression of acetylcholine. Also disclosed are diagnostic methods for detecting a mutation in the human Choline Acetyltransferase nucleic acid sequence.

Antibodies To Interleukin-1 Converting Enzyme Like Apoptosis Protease-3 And 4

View page
US Patent:
6733981, May 11, 2004
Filed:
Jul 2, 2001
Appl. No.:
09/895263
Inventors:
Wei Wu He - Columbia MD
Craig A. Rosen - Laytonsville MD
Peter L. Hudson - Germantown MD
Gregg A. Hastings - Westlake Village CA
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
C12P 2108
US Classification:
435 71, 435 7021, 530350, 5303871, 5303873, 53038815, 53038826, 5303891, 5303913
Abstract:
Disclosed are human interlude-1 converting enzyme like apoptosis proteases-3 and 4 and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and antibodies and antagonists against such polypeptides. Also provided are methods of using the polypeptides, for example, as an antitumor agent, and antiviral agent, and antibodies and antagonists against such polypeptides for example, for treating Alzheimers disease, Parkinsons disease, rheumatoid arthritis and head injury.

Serum Paraoxonase

View page
US Patent:
7026140, Apr 11, 2006
Filed:
Sep 2, 2004
Appl. No.:
10/932269
Inventors:
Peter L. Hudson - Germantown MD, US
Wei Wu He - Columbia MD, US
Steven M. Ruben - Brookville MD, US
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
C12Q 1/70
C12N 5/12
C12N 9/00
C12P 21/08
US Classification:
435 7021, 435 5, 435183, 435326, 530350, 530809, 53038826
Abstract:
Human serum paraoxonase enzyme and DNA (RNA) encoding such serum paraoxonase enzymes are disclosed. Also provided is the procedure for producing such polypeptides by recombinant techniques. Uses of such polypeptides include their use as an antidote for organophosphate poisoning and to prevent neuronal cell death.
Wei He He from Sacramento, CA, age ~70 Get Report